End-to-end solutions for mRNA development and manufacturing
Vaccine Insights 2022; 1(4), 279;
DOI: 10.18609/vac/2022.039
Published: 21 November 2022
FastFacts
Watch the video or read the poster to learn about:
- Common challenges in the development and commercialization of mRNA therapeutic products
- The advantage of choice – why filling only your unique gaps can be the key to speed
- Summary of key foundational analytical and characterization capabilities